Life sciences & health care M&A update: Q3 2017
The aging US population and prevalence of chronic diseases drives demand within the long-term care industry—both for traditional and alternative care models—making it an attractive investment for many health care acquirers. This 'Life sciences & health care M&A update: Q3 2017' provides Deloitte Corporate Finance LLC insights and market data analysis that shed light on M&A trends in the life sciences and health care industry.
Long-term health care M&A trends¹
The long-term health care sector has seen heightened interest from strategic and financial acquirers. M&A drivers include:
- Strong long-term care industry tailwinds: Health care acquirers are seeking stable growth investments supported by long-term, secular trends, in particular, the aging US population and prevalence of chronic diseases requiring long-term patient care. The $334 billion US long-term care market is estimated to reach nearly $550 billion by 2024, representing a compound annual growth rate (CAGR) of 6.4 percent2.
- Expansion of alternative long-term care models: Increasingly the American public is transitioning away from the traditional skilled nursing facility (SNF) model and moved toward alternative long-term care models, such as home health care, adult day care, and long-term acute platforms, which can offer patients a greater degree of autonomy over a traditional SNF. As a result, many portfolio operators are looking to divest their SNF assets and acquire these alternative long-term care models.
- Increased demand for beds driving higher prices: As the US population continues to age and the number of SNFs has remained relatively constant, demand for beds at traditional long-term care facilities has surged and will continue to provide the potential for strong growth. The higher demand for beds has led the average SNF price per bed per year to soar to a new record of $99,200 in 2016, representing a 15 percent price increase over 20153.
This newsletter is a periodic compilation of certain capital markets information. Information contained in this newsletter should not be construed as a recommendation to sell or a recommendation to buy any security. Any reference to or omission of any reference to any company in this newsletter shall not be construed as a recommendation to sell, buy or take any other action with respect to any security of any such company. We are not soliciting any action with respect to any security or company based on this newsletter. This newsletter is published solely for the general information of clients and friends of Deloitte Corporate Finance LLC. It does not take into account the particular investment objectives, financial situation, or needs of individual recipients. Certain transactions, including those involving early stage companies, give rise to substantial risk and are not suitable for all investors. This newsletter is based on information that we consider reliable, but we do not represent that it is accurate or complete, and it should not be relied upon as such. Prediction of future events is inherently subject to both known risks, uncertainties and other factors that may cause actual results to vary materially. We are under no obligation to update the information contained in this newsletter. We and our affiliates and related entities, partners, principals, directors, and employees, including persons involved in the preparation or issuance of this newsletter, may from time to time have “long” and “short” positions in, and buy or sell, the securities, or derivatives (including options) thereof, of companies mentioned herein. The companies mentioned in this newsletter may be: (i) investment banking clients of Deloitte Corporate Finance LLC; or (ii) clients of Deloitte Financial Advisory Services LLP and its related entities. The decision to include any company for mention or discussion in this newsletter is wholly unrelated to any audit or other services that Deloitte Corporate Finance LLC may provide or to any audit services or any services that any of its affiliates or related entities may provide to such company. No part of this newsletter may be copied or duplicated in any form by any means, or redistributed without the prior written consent of Deloitte Corporate Finance LLC.
1 Continuing care retirement community discussion,” Deloitte Financial Advisory Services. September 2017.
2 “US long-term care market analysis,” Grand View Research. August 2017.
3 “The skilled nursing facility price per bed soars to record, assisted living price per unit beats last year's record,” Long Term Care Provider. February 2017.